We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC
SGMO

Delisted

SGMO was delisted on the 4th of May, 2026.

Back to rankings

205 hedge funds and large institutions have $691M invested in SANGAMO THERAPEUTICS INC in 2020 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 77 increasing their positions, 47 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

107% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 15

64% more repeat investments, than reductions

Existing positions increased: 77 | Existing positions reduced: 47

47% more call options, than puts

Call options by funds: $15.5M | Put options by funds: $10.5M

45% more capital invested

Capital invested by funds: $476M → $691M (+$215M)

8% more funds holding

Funds holding: 190 → 205 (+15)

9.43% less ownership

Funds ownership: 64.16% → 54.73% (-9.4%)

Holders
205
Holders Change
+15
Holders Change %
+7.89%
% of All Funds
4.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
31
Increased
77
Reduced
47
Closed
15
Calls
$15.5M
Puts
$10.5M
Net Calls
+$4.97M
Net Calls Change
+$3.77M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$15.2M
2
Two Sigma Investments
Two Sigma Investments
New York
+$10.9M
3
BlackRock
BlackRock
New York
+$8.98M
4
GPP
Great Point Partners
Connecticut
+$8.78M
5
GLA
Great Lakes Advisors
Illinois
+$7.81M

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$14.7M
2
Citadel Advisors
Citadel Advisors
Florida
-$10.6M
3
Millennium Management
Millennium Management
New York
-$9.48M
4
Marshall Wace
Marshall Wace
United Kingdom
-$8.68M
5
TCM
Tang Capital Management
California
-$4.21M
Name Holding Trade Value Shares
Change 		Change in
Stake
EGM
76
Engineers Gate Manager
New York
$712K +$737K +79,424 New
Mirae Asset Global Investments
77
Mirae Asset Global Investments
South Korea
$672K +$250K +26,902 +56%
SEI Investments
78
SEI Investments
Pennsylvania
$648K +$615K +66,288 New
Rafferty Asset Management
79
Rafferty Asset Management
New York
$643K +$524K +56,456 +368%
Arrowstreet Capital
80
Arrowstreet Capital
Massachusetts
$632K -$11.4K -1,231 -2%
AIG
81
American International Group
New York
$631K +$22.4K +2,417 +4%
DA
82
DCF Advisers
Connecticut
$631K +$153K +16,500 +31%
Tudor Investment Corp
83
Tudor Investment Corp
Connecticut
$605K +$627K +67,573 New
RA
84
Royce & Associates
New York
$590K – – –
Simplex Trading
85
Simplex Trading
Illinois
$575K +$376K +40,558 +171%
RJFSA
86
Raymond James Financial Services Advisors
Florida
$568K +$162K +17,496 +38%
State Board of Administration of Florida Retirement System
87
State Board of Administration of Florida Retirement System
Florida
$523K – – –
Invesco
88
Invesco
Georgia
$521K -$55.5K -5,983 -9%
BCM
89
Bayesian Capital Management
New York
$481K -$522K -56,300 -51%
MIM
90
MetLife Investment Management
New Jersey
$474K – – –
TI
91
Trexquant Investment
Connecticut
$471K +$487K +52,527 New
VF
92
Virtu Financial
New York
$443K +$459K +49,426 New
UCFA
93
United Capital Financial Advisors
Texas
$428K -$378K -40,730 -46%
FAAS
94
First Allied Advisory Services
California
$413K +$1.72K +185 +0.4%
Qube Research & Technologies (QRT)
95
Qube Research & Technologies (QRT)
United Kingdom
$412K +$427K +46,006 New
Los Angeles Capital Management
96
Los Angeles Capital Management
California
$399K +$413K +44,492 New
FSA
97
Fort Sheridan Advisors
Illinois
$396K +$17.4K +1,880 +4%
HSBC Holdings
98
HSBC Holdings
United Kingdom
$395K +$112K +12,048 +38%
Principal Financial Group
99
Principal Financial Group
Iowa
$392K +$110K +11,807 +37%
AG
100
Aperio Group
California
$373K +$68.3K +7,358 +21%
2 3
4
5 6

SGMO Hedge Fund Activity: Q2 2020 in Review

205 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q2 2020, worth a combined $691M — up 45% from $476M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new SGMO positions and 15 closed out — a net gain of 16 holders — while 77 added to existing stakes and 47 trimmed.

The largest buyer was State Street, adding an estimated $15.2M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $14.7M sold.

  • 205 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q2 2020, up from 190 in Q1 2020.
  • Funds reported $691M of SANGAMO THERAPEUTICS INC stock for Q2 2020, up 45% quarter-over-quarter.
  • 31 funds opened new SANGAMO THERAPEUTICS INC positions in Q2 2020 and 15 closed out, a net change of +16 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q2 2020 was State Street, an estimated $15.2M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q2 2020 was EcoR1 Capital, an estimated $14.7M sold.

Based on aggregated 13F filings for Q2 2020.